Regulacje i polityka gospodarcza · 5.11.1996

Findings of Scientific Misconduct

Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: Melissa A. Harrington, University of Texas Southwestern Medical Center: Based upon an investigation conducted by the University of Texas Southwestern Medical Center, information obtained by ORI during its oversight review, and Dr. Harrington's own admission, ORI found that Melissa A. Harrington, Ph.D., former postdoctoral research fellow, Department of Pharmacology at the University of Texas Southwestern Medical Center, engaged in scientific misconduct by falsifying the methodology and figures in a manuscript that was accepted for publication in the Journal of Neuroscience (``G q and G y open two Bradykinin-gated potassium channels via a membrane-delimited pathway''). The research was supported by a grant from the National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH). Specifically, ORI found that Dr. Harrington had (1) falsely described the addition of GDP to a G-protein subunit buffer, when she had omitted it from some of the experiments; (2) falsified three figures (a) by falsely depicting the course of a